FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of BioXcel Therapeutics, Inc. - BTAIPRNewsWire • 08/10/23
BioXcel Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 08/09/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/05/23
ROSEN, LEADING TRIAL ATTORNEYS Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 08/04/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/01/23
BioXcel Therapeutics to Report Second Quarter 2023 Financial Results on August 14, 2023GlobeNewsWire • 07/31/23
Kessler Topaz Meltzer & Check, LLP Notification: Deadline Reminder for BioXcel Therapeutics, Inc. (BTAI) Investors in Securities Class Action LawsuitPRNewsWire • 07/30/23
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 07/28/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/28/23
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioXcel Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 07/28/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/24/23
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.PRNewsWire • 07/24/23
BTAI Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioXcel Therapeutics, Inc. (BTAI) and Encourages Investors to Contact the FirmPRNewsWire • 07/21/23
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 07/20/23
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 07/19/23
INVESTOR DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $250,000 to Contact the FirmAccesswire • 07/19/23
BioXcel Therapeutics, Inc. (BTAI) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioXcel Therapeutics, Inc.Business Wire • 07/18/23
BTAI INVESTOR DEADLINE: BioXcel Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 07/15/23
Calling All BioXcel Therapeutics, Inc. (BTAI) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!Business Wire • 07/13/23
ROSEN, A LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAIPRNewsWire • 07/13/23
Attention BioXcel Therapeutics, Inc. (BTAI) Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against BioXcel Therapeutics, Inc.PRNewsWire • 07/12/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioXcel Therapeutics, Inc. (BTAI)Business Wire • 07/11/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioXcel Therapeutics, Inc. (BTAI)Business Wire • 07/11/23
